In recognition of International Overdose Awareness Day, NORML chapters around the country are taking action to highlight the positive that marijuana legalization can play in combating America’s opioid crisis.
Many NORML leaders are hosting community forums to highlight the growing evidence that regulated marijuana access is positively associated with decrease in opioid overdose fatalities, hospitalizations, dependency and use.
To amplify these efforts, NORML has created action alerts targeting local, state, and federal opioid task forces and committees — urging them to make marijuana regulation a part of their discussions and strategies.
Please take just two minutes to use our prewritten letters and send a message to each target:
Opioid-involved overdose deaths have increased five-fold since 1999 and were involved in over 40,000 deaths in 2016. Deaths involving benzodiazepines, a family of anti-anxiety drugs, have increased eight-fold during this same time period.
Several observational studies — such as those here, here, and here — find that medical marijuana regulation is correlated with reductions in opioid-related use, drug spending, abuse, hospitalization, and mortality. Separate data evaluating prescription drug use trends among individual patients enrolled in state-licensed medical marijuana programs is consistent with this conclusion, finding that many chronic pain subjects reduce or eliminate their use of opioids following enrollment.
The available data is consistent and clear. For many patients, cannabis offers a viable alternative to opioids. It is time for lawmakers to stop placing political ideology above the health and safety of the American public, and to acknowledge the safety and efficacy of marijuana as an alternative medical treatment.
